Zeaxanthin couples intracellular Ca2+ homeostasis to CAMKK2/AMPK-dependent mitochondrial recovery in senescent muscle
Abstract
Age-related loss of skeletal muscle is tightly linked to mitochondrial failure, disrupted calcium handling and impaired myogenic maintenance, but strategies that coordinate these processes remain limited. Here we show that zeaxanthin protects against sarcopenia-like muscle atrophy in accelerated-aging and cellular-senescence models. In D-galactose-treated mice, 12 weeks of zeaxanthin preserved dystrophin organization, sarcomeric architecture and mitochondrial ultrastructure, and restored markers of mitochondrial fusion, mitophagy and AMPK-associated quality control. In C2-ceramide-induced C2C12 myotubes, zeaxanthin reduced senescence-associated β-galactosidase activity, maintained myotube morphology, restored mitochondrial content and shifted myogenic and atrophy-related markers toward a less degenerative state. Mechanistically, zeaxanthin stabilized intracellular Ca 2+ distribution across the endoplasmic reticulum, cytosol and mitochondria, reduced pathological mitochondria-associated endoplasmic reticulum membrane coupling and limited mitochondrial Ca 2+ overload. These changes were accompanied by recovery of mitochondrial membrane potential, respiratory capacity and ATP production, and by activation of the CAMKK2/AMPK metabolic axis; CAMKK2 inhibition blunted these bioenergetic and signalling benefits. Thus, zeaxanthin links Ca 2+ -mitochondria-associated ER membrane homeostasis to CAMKK2/AMPK-dependent mitochondrial recovery in preclinical models of sarcopenia-like muscle degeneration.
Related articles
Related articles are currently not available for this article.